how is glp 1 taken The Latest on GLP-1s | Lexington Medical Center Blog GLP-1 | Summary

For example, in the SUSTAIN 5 clinical trial, patients with HbA1c levels of 8.0% or lower had their basal insulin doses reduced by 20% when starting semaglutide therapy to minimize the risk of low blood sugar

Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist with similar effects

Diabetic ketoacidosis In patients with insulindependent diabetes, the risk of DKA is the primary concern

GLP-1 medications are designed to work alongside dietary modifications and increased physical activity, not as standalone solutions

J.PenttilA

"Clinicians know that most of their GLP-1 patients will eventually stop the medication, and without new habits the weight tends to come back," said Geoff Cook, CEO of Noom